Biodexa Pharmaceuticals (BDRX) Inventory (2015 - 2018)
Biodexa Pharmaceuticals (BDRX) posted Inventory of $809376.6 for Q4 2018, down 40.23% sequentially from $1.4 million in Q2 2018, and down 35.22% YoY from $1.2 million in Q4 2017.
Biodexa Pharmaceuticals (BDRX) Inventory (2015 - 2018) Analysis & Trends
Biodexa Pharmaceuticals has reported Inventory for 4 years, with the latest figure at $809376.6 in Q4 2018.
- Quarterly Inventory fell 35.22% year-over-year to $809376.6 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $809376.6 (down 35.22% YoY) and the FY2018 annual result came in at $840066.8, down 30.7% from the prior year.
- Inventory retreated to $809376.6 in Q4 2018 per BDRX's latest filing, from $1.4 million in the prior quarter.
- Over five years, Inventory peaked at $1.4 million in Q2 2018 and troughed at $696528.2 in Q4 2015.
- A 4-year average of $1.1 million and a median of $1.1 million in 2016 frame the typical range for Inventory.
- The sharpest annual moves came in 2016 and 2018: Inventory surged 45.83% in 2016, then slumped 35.22% in 2018.
- Over 4 years, Inventory stood at $696528.2 in 2015, then jumped by 45.83% to $1.0 million in 2016, then climbed by 23.0% to $1.2 million in 2017, then plunged by 35.22% to $809376.6 in 2018.
- According to Business Quant data, Inventory over the past three periods registered $809376.6, $1.4 million, and $1.2 million for Q4 2018, Q2 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 809,376.59 |
| Jun 30, 2018 | 1.35 Mn |
| Dec 31, 2017 | 1.25 Mn |
| Jun 30, 2017 | 1.17 Mn |
| Dec 31, 2016 | 1.02 Mn |
| Jun 30, 2016 | 1.13 Mn |
| Dec 31, 2015 | 696,528.15 |